Brian G. Atwood
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian G. Atwood
Brian G. Atwood is recorded as CEO and Chairman at Cero Therapeutics Holdings, Inc. (CERO). Cero Therapeutics Holdings, Inc. reported in an 8-K filed October 2, 2024 that Brian G. Atwood resigned as Chief Executive Officer, effective September 30, 2024. Cero Therapeutics Holdings, Inc. reported in an 8-K filed September 25, 2024 that Brian G. Atwood resigned as President and CEO. Cero Therapeutics Holdings, Inc. reported in an 8-K filed September 25, 2024 that Brian G. Atwood resigned as Chief Executive Officer. Equibles holds 6 filed executive changes naming Brian G. Atwood; each is listed under recent activity with its source filing. The proxy statement of Cero Therapeutics Holdings, Inc. reports total compensation of $1,806,508 for Brian G. Atwood in fiscal 2024, including a base salary of $225,000.
“As previously disclosed, Brian G. Atwood resigned from his position as Chief Executive Officer, effective on September 30, 2024.”
“Brian Atwood has elected to step down as President and CEO to become a consultant to CERo and to Mr. Ehrlich during this transition; he will remain on the board of directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-14–present
-
Current
2024-02-14–present
-
Start not stated–2024-04-15
Last confirmed by a filing; no departure on record
-
Start not stated–2024-09-25
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Chris Ehrlich CEO, Chairman, Board Member
- Andrew Albert "Al" Kucharchuk CFO
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Charles Carter CFO
- Daniel Corey CTO, Board Member
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
- Michael Byrnes Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cero Therapeutics Holdings, Inc. (CERO) | Former Chief Executive Officer | $225,000 | $1,806,508 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.